Abiopharma

Clinical trial NCT05257473 updates: 1. completion date: 2026-05-01 → 2026-08-01 2. primary completion date: 2026-05-01 → 2026-08-01

Clinical trial NCT04622046 updates: 1. collaborators added: Eidos Therapeutics, a BridgeBio company 2. collaborators removed: Eidos Therapeutics, a BridgeBio, Inc. Company

Clinical trial NCT07249320 updates: 1. enrollment: 39456 → 1 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07388498 updates: 1. completion date: 2028-07-18 → 2028-06-18 2. primary completion date: 2028-05-23 → 2028-06-18

Clinical trial NCT07630961: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06983158 updates: 1. status: SUSPENDED → TERMINATED 2. completion date: 2028-12-20 → 2026-05-26 3. primary completion date: 2028-12-20 → 2026-03-25 4. enrollment: 12 → 1 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT00916682 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: not set → 2013-06-05 3. primary completion date: 2010-02-01 → 2013-06-05 4. enrollment: 200 → 273 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07540897: start date: 2026-05-01 → 2026-06-01.

Clinical trial NCT07415876: start date: 2026-04-01 → 2026-06-04.

Clinical trial NCT07477704 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-14 → 2026-06-29 3. completion date: 2027-03-09 → 2027-02-23 4. primary completion date: 2026-10-20 → 2026-12-29